Cargando…
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simu...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161019/ https://www.ncbi.nlm.nih.gov/pubmed/21801345 http://dx.doi.org/10.1186/1475-2875-10-210 |
_version_ | 1782210625704820736 |
---|---|
author | Kern, Steven E Tiono, Alfred B Makanga, Michael Gbadoé, Adama Dodji Premji, Zulfiqarali Gaye, Oumar Sagara, Issaka Ubben, David Cousin, Marc Oladiran, Fiyinfolu Sander, Oliver Ogutu, Bernhards |
author_facet | Kern, Steven E Tiono, Alfred B Makanga, Michael Gbadoé, Adama Dodji Premji, Zulfiqarali Gaye, Oumar Sagara, Issaka Ubben, David Cousin, Marc Oladiran, Fiyinfolu Sander, Oliver Ogutu, Bernhards |
author_sort | Kern, Steven E |
collection | PubMed |
description | BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simulation, this analysis explored the impact of community screening campaigns (CSC) followed by systematic treatment of P. falciparum asymptomatic carriers (AC) with artemether-lumefantrine (AL) on disease transmission. The model created by Okell et al (originally designed to explore the impact of the introduction of treatment with artemisinin-based combination therapy on malaria endemicity) was modified to represent CSC and treatment of AC with AL, with the addition of malaria vector seasonality. The age grouping, relative distribution of age in a region, and degree of heterogeneity in disease transmission were maintained. The number and frequency of CSC and their relative timing were explored in terms of their effect on malaria incidence. A sensitivity analysis was conducted to determine the factors with the greatest impact on the model predictions. RESULTS: The simulation showed that the intervention that had the largest effect was performed in an area with high endemicity (entomological inoculation rate, EIR > 200); however, the rate of infection returned to its normal level in the subsequent year, unless the intervention was repeated. In areas with low disease burden (EIR < 10), the reduction was sustained for over three years after a single intervention. Three CSC scheduled in close succession (monthly intervals) at the start of the dry season had the greatest impact on the success of the intervention. CONCLUSIONS: Community screening and treatment of asymptomatic carriers with AL may reduce malaria transmission significantly. The initial level of disease intensity has the greatest impact on the potential magnitude and duration of malaria reduction. When combined with other interventions (e.g. long-lasting insecticide-treated nets, rapid diagnostic tests, prompt diagnosis and treatment, and, where appropriate, indoor residual spraying) the effect of this intervention can be sustained for many years, and it could become a tool to accelerate the reduction in transmission intensity to pre-elimination levels. Repeated interventions at least every other year may help to prolong the effect. The use of an effective diagnostic tool and a highly effective ACT, such as AL, is also vital. The modelling supports the evaluation of this approach in a prospective clinical trial to reduce the pool of infective vectors for malaria transmission in an area with marked seasonality. |
format | Online Article Text |
id | pubmed-3161019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31610192011-08-25 Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis Kern, Steven E Tiono, Alfred B Makanga, Michael Gbadoé, Adama Dodji Premji, Zulfiqarali Gaye, Oumar Sagara, Issaka Ubben, David Cousin, Marc Oladiran, Fiyinfolu Sander, Oliver Ogutu, Bernhards Malar J Research BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simulation, this analysis explored the impact of community screening campaigns (CSC) followed by systematic treatment of P. falciparum asymptomatic carriers (AC) with artemether-lumefantrine (AL) on disease transmission. The model created by Okell et al (originally designed to explore the impact of the introduction of treatment with artemisinin-based combination therapy on malaria endemicity) was modified to represent CSC and treatment of AC with AL, with the addition of malaria vector seasonality. The age grouping, relative distribution of age in a region, and degree of heterogeneity in disease transmission were maintained. The number and frequency of CSC and their relative timing were explored in terms of their effect on malaria incidence. A sensitivity analysis was conducted to determine the factors with the greatest impact on the model predictions. RESULTS: The simulation showed that the intervention that had the largest effect was performed in an area with high endemicity (entomological inoculation rate, EIR > 200); however, the rate of infection returned to its normal level in the subsequent year, unless the intervention was repeated. In areas with low disease burden (EIR < 10), the reduction was sustained for over three years after a single intervention. Three CSC scheduled in close succession (monthly intervals) at the start of the dry season had the greatest impact on the success of the intervention. CONCLUSIONS: Community screening and treatment of asymptomatic carriers with AL may reduce malaria transmission significantly. The initial level of disease intensity has the greatest impact on the potential magnitude and duration of malaria reduction. When combined with other interventions (e.g. long-lasting insecticide-treated nets, rapid diagnostic tests, prompt diagnosis and treatment, and, where appropriate, indoor residual spraying) the effect of this intervention can be sustained for many years, and it could become a tool to accelerate the reduction in transmission intensity to pre-elimination levels. Repeated interventions at least every other year may help to prolong the effect. The use of an effective diagnostic tool and a highly effective ACT, such as AL, is also vital. The modelling supports the evaluation of this approach in a prospective clinical trial to reduce the pool of infective vectors for malaria transmission in an area with marked seasonality. BioMed Central 2011-07-29 /pmc/articles/PMC3161019/ /pubmed/21801345 http://dx.doi.org/10.1186/1475-2875-10-210 Text en Copyright ©2011 Kern et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kern, Steven E Tiono, Alfred B Makanga, Michael Gbadoé, Adama Dodji Premji, Zulfiqarali Gaye, Oumar Sagara, Issaka Ubben, David Cousin, Marc Oladiran, Fiyinfolu Sander, Oliver Ogutu, Bernhards Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis |
title | Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis |
title_full | Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis |
title_fullStr | Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis |
title_full_unstemmed | Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis |
title_short | Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis |
title_sort | community screening and treatment of asymptomatic carriers of plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161019/ https://www.ncbi.nlm.nih.gov/pubmed/21801345 http://dx.doi.org/10.1186/1475-2875-10-210 |
work_keys_str_mv | AT kernstevene communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT tionoalfredb communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT makangamichael communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT gbadoeadamadodji communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT premjizulfiqarali communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT gayeoumar communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT sagaraissaka communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT ubbendavid communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT cousinmarc communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT oladiranfiyinfolu communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT sanderoliver communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis AT ogutubernhards communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis |